Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS).
about
Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney diseaseHeparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adultsComparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controBenefits and harms of citrate locking solutions for hemodialysis catheters: a systematic review and meta-analysisMicrobial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens).Hemodialysis Tunneled Catheter Noninfectious Complications.Trisodium citrate: an alternative to unfractionated heparin for hemodialysis catheter dwells.Catheter dysfunction: the role of lock solutions.Vascular access in therapeutic apheresis: update 2013.Use of tissue plasminogen activator in catheters used for extracorporeal renal replacement therapy.Urokinase-containing locking solution in the prevention of dialysis catheter dysfunction: a double blind randomized controlled trial.Comparative effectiveness of 30 % trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters: a randomized controlled trial (CITRIM trial).Anticoagulant therapies versus heparin for the prevention of hemodialysis catheter-related complications: systematic review and meta-analysis of prospective randomized controlled trials.RETRACTED ARTICLE: Anticoagulant agents for the prevention of hemodialysis catheter-related complications: systematic review and meta-analysis of prospective randomized controlled trials.Does antimicrobial lock solution reduce catheter-related infections in hemodialysis patients with central venous catheters? A Bayesian network meta-analysis.Minimizing hemodialysis catheter dysfunction: an ounce of prevention.Acid-citrate-dextrose Formula A versus heparin as primary catheter lock solutions for therapeutic apheresis.Catheter outcomes in the short-term inpatient setting: a controlled quality improvement study comparing citrate and heparin lock.Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis.Chronic Hemodialysis in Small Children.
P2860
Q24185924-71AA1187-BCEF-40F9-8FCD-260627407EC0Q24193149-101DC1F2-3EE9-482C-AA6D-42C009135E90Q34895169-4A2CEE69-95A9-45A0-B4E9-C5F419E71E14Q35551393-4DA38907-96DD-4D8E-8F4A-EE59737ED3A8Q37198684-1C4D9CD9-D673-4D20-B0EA-F566E29790A7Q37674559-EC77F473-16A3-40B6-AAE6-8261E1651327Q37802887-A99FF440-D69E-48D6-B282-BAC5DA769632Q37969142-C705EB46-70E6-450B-9502-B8600E4F16F3Q38082736-FB9B4744-A5F6-44CF-858E-3F44BB01632CQ38179478-55248EAC-FF23-4D4F-A6FB-50C920E2104DQ38375466-FEE5D8DC-D8F0-4BAA-A721-D74BF19279DDQ38385564-03AFC255-43C1-4A09-82D0-32DAE59614C5Q38628552-F6D8F276-DBD7-4AD9-9888-77D8E37D4E41Q38650815-855A82F1-5EAC-4A7E-86C6-48C8E8FB330EQ39051353-70DB786C-3686-4C13-B3B8-A9C13BD4367FQ41978574-6C201392-8896-4B86-9294-6558CA326492Q44622061-8713725D-6D92-41FA-8D83-C589BBA30D90Q46552875-B72A93F4-A4EF-499D-8C43-53E94F3A7CF3Q50512175-0E94F1B8-1D16-4FB0-8E53-59E8297E15F9Q51288024-946F6268-52C3-4AE4-87B8-89487FA7282C
P2860
Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS).
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS).
@ast
Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS).
@en
type
label
Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS).
@ast
Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS).
@en
prefLabel
Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS).
@ast
Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS).
@en
P2093
P2860
P356
P1476
Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS)
@en
P2093
Adeera Levin
Beverly Jung
Ivana Dojcinovic
Mercedeh Kiaii
Ognjenka Djurdjev
Steven Shalansky
P2860
P304
P356
10.2215/CJN.01760407
P577
2008-03-01T00:00:00Z